HILLARY SMITH: Open Payments
NPI 1548721426 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 6 companies in 2025. Trend: 2023 $119 · 2024 $0 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| Alkermes, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: INGREZZA, SPRAVATO, ARISTADA, INVEGA SUSTENNA, TRINTELLIX, Auvelity, CAPLYTA.
Industry payments across TX — which companies pay providers there.
